Moreover, quercetin and glabrol, the components of Glycyrrhiza glabra, not only showed selective inhibition of CYP1B1 in breast cancer cells but also were able to reverse cisplatin resistance in CYP1B1 overexpressing MDA-MB-468 (TNBC) cells [62]. This evidence concerns the gene CYP1B1 and breast carcinoma.